rdf:type |
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0017262,
umls-concept:C0020094,
umls-concept:C0085358,
umls-concept:C0185117,
umls-concept:C1332717,
umls-concept:C1413244,
umls-concept:C1413357,
umls-concept:C1446409,
umls-concept:C1516670,
umls-concept:C1706438,
umls-concept:C2698600,
umls-concept:C2911684
|
pubmed:issue |
2
|
pubmed:dateCreated |
2010-10-11
|
pubmed:abstractText |
Here we investigate the mechanisms by which HTLV-1 infection prevents the cell death of CD8(+) T cells in vivo. We show that upon natural infection, cloned CD8(+) but not CD4(+) cells from patients without malignancy become resistant to Fas-mediated cell death and acquire an antiapoptotic transcriptome that includes the overexpression of cIAP-2 and c-FLIP(L). CD8(+) lymphocyte-restricted cIAP-2 overexpression correlates with resistance to Fas-mediated apoptosis and depends on tax expression via NF-KappaB. In contrast, in the same CD8(+) cells, the HTLV-1-dependent overexpression of c-FLIP(L) does not correlate with resistance to Fas-mediated cell death nor with tax expression. In the present model, infected CD8(+) clones are the only cell subtype in which cIAP-2 expression correlates with resistance to cell death. These results support a role for Tax-dependent cIAP-2 expression in preventing the death of naturally infected CD8(+) cells and thereby in their clonal expansion in vivo.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1096-0341
|
pubmed:author |
pubmed-author:Delfau-LarueMarie-HélèneMH,
pubmed-author:GessainAntoineA,
pubmed-author:GoutOlivierO,
pubmed-author:LachuerJoëlJ,
pubmed-author:LançonAgnèsA,
pubmed-author:LegrasCatherineC,
pubmed-author:MehlenPatrickP,
pubmed-author:MortreuxFranckF,
pubmed-author:PinatelChristianeC,
pubmed-author:SibonDavidD,
pubmed-author:WattelEricE,
pubmed-author:WierinckxAnneA,
pubmed-author:ZaneLindaL
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
25
|
pubmed:volume |
407
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
341-51
|
pubmed:meshHeading |
pubmed-meshheading:20863547-Antigens, CD95,
pubmed-meshheading:20863547-Apoptosis,
pubmed-meshheading:20863547-CASP8 and FADD-Like Apoptosis Regulating Protein,
pubmed-meshheading:20863547-CD4-Positive T-Lymphocytes,
pubmed-meshheading:20863547-CD8-Positive T-Lymphocytes,
pubmed-meshheading:20863547-Cell Proliferation,
pubmed-meshheading:20863547-Cell Survival,
pubmed-meshheading:20863547-Clone Cells,
pubmed-meshheading:20863547-Gene Products, tax,
pubmed-meshheading:20863547-HTLV-I Infections,
pubmed-meshheading:20863547-Human T-lymphotropic virus 1,
pubmed-meshheading:20863547-Humans,
pubmed-meshheading:20863547-Inhibitor of Apoptosis Proteins
|
pubmed:year |
2010
|
pubmed:articleTitle |
Clonal expansion of HTLV-1 positive CD8+ cells relies on cIAP-2 but not on c-FLIP expression.
|
pubmed:affiliation |
CNRS UMR5239, Université de Lyon, Oncovirologie et Biothérapies, Centre Léon Bérard, 69008 Lyon, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|